Overview
News
Salaries
Products
People
Growth
Offices
Financials

Overview

We expedites biomarker discovery and diagnostic development. Our focus is developing novel blood tests for early detection of ovarian and pancreatic cancers.

News

Blog 1 year ago
UK Department of Business & Trade genomics spotlight
GenoME was honoured to be profiled in the Department of Business and Trade celebration of a decade of genomics. The publication highlights the various successes across different genomics sectors in UK. Read the full article at Life Sciences… Source
Read more
Report
Blog 1 year ago
GenoME named as 1 of 8 top biotechs to watch
GenoME Diagnostics was delighted to be listed as one of the eight top biotechs to watch alongside the highly prestigious Sunday Times Top 100 Growth Companies. GenoME was profiled alongside some industry giants in recognition of our development. Read the
Read more
Report
Award 3 years ago
GenoME announced as winners of the Best EIS Investment 2023
GenoME were delighted to be announced as the Best EIS Investment at the Enterprise Investment Scheme Association awards. This was in recognition of the recent closure of GenoME Diagnostic's Seed investment round. Read the full article on LinkedIn… Source
Read more
Report
Blog 3 years ago
GenoME profiled in GenomeWeb publication
GenoME was recently spotlighted in the industry publication GenomeWeb. The article highlight GenoME's innovation to develop a digital PCR0based ovarian cancer test. Read the full article on GenomeWeb… Source
Read more
Report
Press release 3 years ago
GenoME Diagnostics closes £1.4m funding round
GenoME Diagnostics has closed its Seed funding round to further develop its novel technologies. The company said the funding round - which was supported by QUBIS, the commercialisation arm of QUB…
Read more
Report
Blog 3 years ago
GenoME Diagnostics announces pancreatic cancer collaboration with Queen's University
A collaboration between GenoME Diagnostics and Queen's University Belfast has been awarded a £500k InnovateUK grant to boost development of an early detection pancreatic cancer blood test. Read the full article here - Belfast company secures £1.4m funding
Read more
Report
Award 4 years ago
Lisburn woman in ovarian cancer diagnostic firm wins £50,000 at top innovation awards
A leading female researcher at Queen's University commercial spin-out, GenoME Diagnostics, has won £50,000 and a mentoring and support package after being named a winner at Innovate UK's Women in Innovation Awards. Dr Shannon Beattie from Hillsborough is
Read more
Report
Award 4 years ago
Dr Shannon Beattie receives Women in Innovation Award
GenoME CEO Shannon Beattie was recognised as 1 of 39 women across the UK by a Women In Innovation Award from InnovateUK. GenoME Diagnostics' project has involved isolating a number of biomarkers that can potentially be detected in a patient's blood. If a
Read more
Report
Press release 5 years ago
GenoME Diagnostics closes pre-seed funding round
The Queen's University Belfast spin-out develops novel blood tests for earlier and more accurate detection of ovarian cancer. The cutting-edge technology can produce cost-effective diagnostics…
Read more
Report
Blog 5 years ago
Dr Shannon Beattie featured as Entrepreneur of the Month
Dr Beattie and GenoME were featured in the latest edition of Ulster Business, with Dr Beattie recognised as Entrepreneur Of The Month. Read the full article in Ulster Business… Source
Read more
Report